Neotron Pharma is available to support customers with screenings, validation activities and excipients interaction studies.
As reported in the latest revision EMA/409815/2020 Rev. 17 of 28 July 2023, the regulatory authority has updated the list of Nitrosamines to be monitored by also introducing Nitroso APIs and the relative limit for these molecules.
Thanks to its extensive experience in the analysis of excipients, APIs and PFs. Neotron Pharma is the ideal partner to satisfy the analytical requests of the authority.
NEOTRON PROPOSAL
About Neotron
Neotron is a premier European provider of analytical services, specializing in food, feed, pharmaceuticals, and cosmetics. With a focus on precise testing, sensory analysis, and R&D, Neotron ensures compliance with the highest global standards. As an accredited lab Neotron delivers innovative, tailored solutions to meet the diverse product development and quality control needs of its clients.